The duration of a protective level of yellow fever antibodies after autologous hematopoietic stem cell transplantation in a previously vaccinated person is unclear.
Kayoko Hayakawa +10 more
doaj +2 more sources
Hematopoietic stem cell transplantation for the management of follicular lymphoma
Chitra HosingDepartment of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USAAbstract: Although much has been published on the application of autologous and allogeneic hematopoietic ...
Chitra Hosing
doaj +1 more source
To evaluate whether patients with multiple myeloma (MM) could benefit from tandem autologous hematopoietic stem cell transplantation (auto-HSCT), PubMed, Embase, Web of Science and Cochrane Library databases were systematically searched, and 10 eligible ...
Hongtao Li +3 more
doaj +2 more sources
Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis
Multiple sclerosis (MS) is a chronic inflammatory disease of central nervous system (CNS), which is disabling and majorly involves younger population. Various available treatments in forms of immunomodulation are not very effective; however, stem cell ...
Awadh Kishor Pandit +2 more
doaj +2 more sources
Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases [PDF]
Ten years have passed since the first published consensus statement on the use of hematopoietic stem cell transplantation (HSCT) in the treatment of severe autoimmune disease (AD) appeared. During that time, around 700 patients suffering from severe AD have undergone HSCT in the frame of phase I/II clinical trials from over 20 countries including the ...
Tyndall A, Daikeler T
openaire +8 more sources
Optimizing Autologous Hematopoietic Stem Cell Transplantation for Acute Leukemia [PDF]
Abstract Autologous hematopoietic stem cell transplantation (ASCT) remains an important postremission treatment for acute leukemia (AL). It is known that some prognostic factors, such as age, cytogenetic and molecular risk stratification, and minimal residual disease (MRD) status, are closely related to clinical outcomes following ASCT ...
Aiming Pang +6 more
openaire +3 more sources
Blood stem cell collections after mobilization with combination chemotherapy containing ifosfamide followed by G-CSF in multiple myeloma [PDF]
High-dose chemotherapy with autologous peripheral blood stem cell transplantation is the standard treatment of patients with multiple myeloma today. In this study we used a combination mobilizing chemotherapy containing ifosfamide with G-CSF before stem ...
Werding, N. +5 more
core +2 more sources
Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a global observational study [PDF]
Fifty-five years after publication of the first hematopoietic stem cell transplantation this technique has become an accepted treatment option for defined hematologic and non-hematologic disorders.
Madrigal, Alejandro +31 more
core +1 more source
Autologous hematopoietic stem cell transplantation (auto-HSCT) in children in Poland: 2021 indications and practice [PDF]
Unlike in adults, the number of pediatric autologous hematopoietic stem cell transplants (HSCT) has decreased in last years. This is because of changing indications for this type of treatment and new therapies available in recent years.
Drabko, Katarzyna; Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, Lublin, Poland
core +1 more source
The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor [PDF]
Mobilized blood has supplanted bone marrow (BM) as the primary source of hematopoietic stem cells for autologous and allogeneic stem cell transplantation.
Dembowsky, K. +38 more
core +1 more source

